These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7234453

  • 1. Drug-induced alterations of the hypothalamus-hypophysis axis.
    Mazzi C, Riva LP, Morandi G, Mainini E, Martinelli I, Bertaccini G.
    Acta Psychiatr Belg; 1980; 80(5):619-37. PubMed ID: 7234453
    [Abstract] [Full Text] [Related]

  • 2. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC, Bang F, Laurberg P.
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [Abstract] [Full Text] [Related]

  • 3. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 4. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F, Genazzani AR, Camanni F, De Leo V, Molinatti GM, Müller EE.
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
    Kamoi K, Tchuchida I, Sato H, Tanaka R, Ishiguro T, Kaneko K, Iwasaki Y, Shibata A.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A role for dopamine in growth hormone regulation in the dog.
    Casanueva F, Betti R, Cocchi D, Zanardi P, Motta T, Müller EE.
    Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276
    [Abstract] [Full Text] [Related]

  • 10. Failure of drugs acting on H2-receptors to modify plasma prolactin levels in pituitary adenomas: evidence for a suprapituitary locus of action.
    Scarpignato C, Valenti G, Ceda GP, Bertaccini G.
    Int Pharmacopsychiatry; 1981 Apr; 16(2):79-83. PubMed ID: 7333790
    [Abstract] [Full Text] [Related]

  • 11. Tubero-infundibular dopaminergic function in cirrhotic patients: evaluation by nomifensine and domperidone.
    Monza GC, Lampertico M, Locatelli S, Sali L, Cocchi D.
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):315-20. PubMed ID: 6880568
    [Abstract] [Full Text] [Related]

  • 12. Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
    Ferrari C, Crosignani PG, Caldara R, Picciotti MC, Malinverni A, Barattini B, Rampini P, Telloli P.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):23-6. PubMed ID: 7188615
    [Abstract] [Full Text] [Related]

  • 13. The effect of nomifensine on thyroid-stimulating hormone (TSH) in normal and hyperprolactinemic subjects.
    Giusti M, Mazzocchi G, Mignone D, Tarditi W, Contessini M, Bessarione D, Giordano G.
    Neuroendocrinology; 1983 Dec; 37(6):406-10. PubMed ID: 6657002
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone tests.
    Molinatti GM, Camanni F, Cocchi D, De Leo V, Genazzni AR, Massara F, Muller EE.
    Panminerva Med; 1981 Dec; 23(1):5-10. PubMed ID: 7290727
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
    Ghigo E, Ciccarelli E, Bianchi SD, Gatti G, Molinatti GM, Massara F, Müller EE, Camanni F.
    Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
    [Abstract] [Full Text] [Related]

  • 18. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE, Loda G, Roggia A, Scagliola P, Falsetti L.
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [Abstract] [Full Text] [Related]

  • 19. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 20. Cortisol secretion following nomifensine administration in normal subjects.
    Alagna S, Masala A.
    Biomedicine; 1979 Nov; 31(7):189-91. PubMed ID: 526541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.